Product Description
Product Name: Eleftha 375 mg Injection
Active Ingredient: Trastuzumab
Strength: 375 mg
Form: Lyophilized Powder for Intravenous Infusion
Category: Anticancer / Monoclonal Antibody / HER2 Inhibitor
Indication: HER2-Positive Breast Cancer, Gastric (Stomach) Cancer, and Esophageal Cancer
Eleftha 375 mg Injection contains Trastuzumab, a monoclonal antibody specifically designed to target HER2 receptors, which are overexpressed in certain types of cancer. It is used in the treatment of HER2-positive breast cancer, gastric cancer, and esophageal cancer, either as monotherapy or in combination with chemotherapy.
